Target small firms for antibiotic innovation-Reference-Cited by-同舟云学术

Target small firms for antibiotic innovation

Published:2014-05-30 Issue:6187 Volume:344 Page:967-969
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Hwang Thomas J.¹²,Carpenter Daniel¹³,Kesselheim Aaron S.²

Affiliation:

1. Faculty of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.

2. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

3. Radcliffe Institute for Advanced Study, Harvard University, Cambridge, MA 02138, USA.

Abstract

Once in clinical trials, antibiotics are more likely to survive than drugs in other classes

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference9 articles.

1. The future challenges facing the development of new antimicrobial drugs

2. A comprehensive regulatory framework to address the unmet need for new antibacterial treatments

3. Why is big Pharma getting out of antibacterial drug discovery?

4. 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

5. Stock Market Returns and Clinical Trial Results of Investigational Compounds: An Event Study Analysis of Large Biopharmaceutical Companies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities;The Lancet Infectious Diseases;2020-07

2. IP-Based Incentives Against Antimicrobial Crisis: A European Perspective;IIC - International Review of Intellectual Property and Competition Law;2019-01

3. Effect of US Food and Drug Administration's Cardiovascular Safety Guidance on Diabetes Drug Development;Clinical Pharmacology & Therapeutics;2017-05-27

4. The Antibiotic Future;Topics in Medicinal Chemistry;2017

5. Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals;Bioorganic & Medicinal Chemistry;2016-12